Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update.
Gronwald J, Tung N, Foulkes WD, Offit K, Gershoni R, Daly M, Kim-Sing C, Olsson H, Ainsworth P, Eisen A, Saal H, Friedman E, Olopade O, Osborne M, Weitzel J, Lynch H, Ghadirian P, Lubinski J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.
Gronwald J, et al. Among authors: lynch h.
Int J Cancer. 2006 May 1;118(9):2281-4. doi: 10.1002/ijc.21536.
Int J Cancer. 2006.
PMID: 16331614